Stockholder’s Equity (Deficit) (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 28, 2026 |
Nov. 30, 2025 |
Oct. 09, 2025 |
Aug. 09, 2025 |
Aug. 01, 2025 |
Jul. 16, 2025 |
May 07, 2025 |
Sep. 02, 2025 |
Jul. 25, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Sep. 30, 2025 |
Apr. 10, 2026 |
Mar. 12, 2026 |
Feb. 26, 2026 |
Jan. 04, 2026 |
Aug. 07, 2025 |
Aug. 04, 2025 |
Jul. 14, 2025 |
May 22, 2025 |
Apr. 28, 2025 |
|
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||||
| Preferred stock, shares authorized | 10,000,000 | 10,000,000 | 10,000,000 | |||||||||||||||||||||
| Preferred stock, par value | $ 0.01 | $ 0.01 | $ 0.01 | |||||||||||||||||||||
| Preferred stock, shares issued | 0 | 0 | 0 | |||||||||||||||||||||
| Preferred stock, shares outstanding | 0 | 0 | 0 | |||||||||||||||||||||
| Common stock, shares authorized | 150,000,000 | 150,000,000 | 150,000,000 | |||||||||||||||||||||
| Common stock, par value | $ 0.01 | $ 0.01 | $ 0.01 | |||||||||||||||||||||
| Class of Warrant or Right, Unissued | 6,900,000 | 6,900,000 | ||||||||||||||||||||||
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.01 | $ 0.01 | ||||||||||||||||||||||
| Sale of Stock, Price Per Share | $ 18.00 | $ 18.00 | $ 0.001 | |||||||||||||||||||||
| Exercise of warrants, share | 0 | 542,256 | ||||||||||||||||||||||
| Class of Warrant or Right, Outstanding | 8,396,069 | 8,396,069 | 7,304,992 | |||||||||||||||||||||
| Warrants issuance | $ 1,333,333 | |||||||||||||||||||||||
| Shares issued | 7,000,000 | 280,534 | ||||||||||||||||||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross | 500,000 | 6,350,000 | ||||||||||||||||||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period | 4 years | |||||||||||||||||||||||
| Granted share option | $ 30,000 | $ 60,000 | $ 500,000 | |||||||||||||||||||||
| General and Administrative Expense | $ 5,989,701 | $ 132,933 | $ 13,592,558 | $ 408,164 | ||||||||||||||||||||
| Intrinsic value of outstanding options | 515,000 | 515,000 | $ 14,429,000 | |||||||||||||||||||||
| Vested and exercisable | 500,000 | |||||||||||||||||||||||
| Employee Benefits and Share-Based Compensation | 110,127 | 0 | $ 0 | 298,348 | ||||||||||||||||||||
| Deferred Compensation Equity | 36,713 | 36,713 | $ 150,000 | |||||||||||||||||||||
| [custom:IssuanceOfSharesToFormerDirectorsDescription] | On August 9, 2025, the Company entered into compensation agreements with three former directors, pursuant to which each director will receive $120,000 payable in cash or shares. Two directors elected to receive a total of $125,000 in shares and on September 10, 2025, total shares of 10,927 were issued and stock-based compensation of $125,000 related the compensation agreements with two former directors was included in general and administrative expense on the consolidated statements of operations during the year ended September 30, 2025. There was no issuance of shares for the three and nine months ended June 30, | |||||||||||||||||||||||
| Common stock share issued | 200,000 | |||||||||||||||||||||||
| Common Stock Fair Value Issued | 470,000 | |||||||||||||||||||||||
| Stock Issued During Period, Shares, Issued for Services | 22,500 | |||||||||||||||||||||||
| consulting agreement Description | On May 7, 2026, pursuant to a May 6, 2026 consulting agreement with a vendor, the Company issued 55,000 shares with a fair value on grant date of $331,150 for services to be rendered from May 2026 to October 2026. For the three and nine months ended June 30, 2026 and 2025, the Company recorded stock-based compensation expense related to the agreement of $112,384 and $0, respectively, and $112,384 and $0 in the nine months ended June 30, 2026 and 2025, respectively. At June 30, 2026 and September 30, 2025, unearned compensation is $224,766 and $0, respectively and will be recognized in the future. | |||||||||||||||||||||||
| Shares issued to directors | $ 40,000 | 40,000 | 0 | |||||||||||||||||||||
| RSUs stock based compensation | $ 75,000 | 218,221 | ||||||||||||||||||||||
| Equity component value | $ 350,000 | |||||||||||||||||||||||
| Issuance of shares | 35,000 | 35,000 | ||||||||||||||||||||||
| Share price | $ 10.00 | $ 10.00 | ||||||||||||||||||||||
| Stock-based compensation liability | $ 350,000 | |||||||||||||||||||||||
| Compensation Payables | $ 100,000 | $ 100,000 | ||||||||||||||||||||||
| additional shares issued | 83,825 | |||||||||||||||||||||||
| Stock based compensation | $ 5,921,134 | |||||||||||||||||||||||
| Saver One Management [Member] | ||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||||
| Stock based compensation | $ 360,448 | |||||||||||||||||||||||
| Common Stock [Member] | ||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||||
| Issuance of shares in asset acquisition, shares | 8,532 | 1,500,000 | ||||||||||||||||||||||
| Public Rights [Member] | ||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||||
| Convertible Preferred Stock, Shares Issued upon Conversion | 6,900,000 | |||||||||||||||||||||||
| Private Rights [Member] | ||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||||
| Convertible Preferred Stock, Shares Issued upon Conversion | 406,000 | |||||||||||||||||||||||
| Warrants [Member] | ||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||||
| Intrinsic value | $ 1,287,000 | $ 1,287,000 | 0 | |||||||||||||||||||||
| Omnibus Equity Incentive Plan [Member] | ||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||||
| Shares issued | 7,000,000 | |||||||||||||||||||||||
| Private Placement [Member] | ||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||||
| Class of Warrant or Right, Unissued | 406,000 | 406,000 | ||||||||||||||||||||||
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 11.50 | $ 11.50 | ||||||||||||||||||||||
| IPO [Member] | ||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||||
| Class of Warrant or Right, Unissued | 6,900,000 | 6,900,000 | ||||||||||||||||||||||
| Equity Option [Member] | ||||||||||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||||||||||
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 3.27 | $ 9.09 | $ 9.09 | $ 7.47 | $ 9.26 | $ 7.2 | ||||||||||||||||||
| General and Administrative Expense | $ 1,122,429 | $ 0 | $ 0 | $ 4,251,373 | ||||||||||||||||||||
| compensation expense | $ 1,452,240 | |||||||||||||||||||||||